Showing results (961-970 of 8,142) with videos related to
Sort By:
Pageof 815
Haematologica|March 16, 2012
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromesNorbert Gattermann, Carlo Finelli, Matteo Della Porta, et al.Haematologica|March 16, 2012
Highly activated and expanded natural killer cells for multiple myeloma immunotherapyTarun K Garg, Susann M Szmania, Junaid A Khan, et al.Haematologica|January 1, 1990
Characterization with a simple clotting assay of the tissue factor inhibiting activity in serumM Cassetti, D Minestrini, G PalazzesiHaematologica|November 9, 2014
The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infectionLuca Arcaini, Davide Rossi, Marco Lucioni, et al.Haematologica|November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.Haematologica|October 26, 2014
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patientsCecilie Blimark, Erik Holmberg, Ulf-Henrik Mellqvist, et al.Haematologica|November 2, 2014
Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndromeYoushan Zhao, Dong Wu, Chengming Fei, et al.Haematologica|February 22, 2000
Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1)Y Rombos, R Tzanetea, K Konstantopoulos, et al.Haematologica|February 22, 2000
Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicinE Knaust, A Porwit-MacDonald, A Gruber, et al.Haematologica|February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registryC Stelitano, L Baldini, C Pieresca, et al.Pageof 815